1. Home
  2. GTN vs EBS Comparison

GTN vs EBS Comparison

Compare GTN & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GTN

Gray Television Inc.

HOLD

Current Price

$3.84

Market Cap

432.5M

Sector

Industrials

ML Signal

HOLD

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$7.50

Market Cap

413.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTN
EBS
Founded
1897
1998
Country
United States
United States
Employees
9582
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
432.5M
413.3M
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
GTN
EBS
Price
$3.84
$7.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$8.50
$12.00
AVG Volume (30 Days)
1.4M
978.6K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
5.79%
N/A
EPS Growth
N/A
125.83
EPS
N/A
0.07
Revenue
N/A
$742,900,000.00
Revenue This Year
$13.89
$1.29
Revenue Next Year
N/A
N/A
P/E Ratio
$11.72
$108.29
Revenue Growth
N/A
N/A
52 Week Low
$3.50
$5.62
52 Week High
$6.44
$14.06

Technical Indicators

Market Signals
Indicator
GTN
EBS
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
GTN
EBS

About GTN Gray Television Inc.

Gray Media Inc is a multimedia company. The company owns and operates local television stations and digital assets. It also owns Gray Digital Media, a full-service digital agency offering national and local clients digital marketing strategies with digital products and services. Its additional media properties include video production companies Raycom Sports, Tupelo Media Group, and PowerNation Studios, and studio production facilities Assembly Atlanta and Third Rail Studios. The company's segments include Broadcasting and Production Companies. The majority of revenue is derived from broadcast and digital advertising and from retransmission consent fees.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: